We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+19.7%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$135B
AUM Growth
+$13.3B
(+11%)
Cap. Flow
-$5.25B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
29.97%
Holding
330
New
19
Increased
69
Reduced
193
Closed
11
Avg Time Held
4.5
years
Top 10 Avg Time Held
5.2
years
Top 20 Avg Time Held
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$693M |
| 2 |
Intel
INTC
|
+$349M |
| 3 |
Goldman Sachs
GS
|
+$161M |
| 4 |
Kyntra Bio
KYNB
|
+$90.1M |
| 5 |
DoorDash
DASH
|
+$69.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$844M |
| 2 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$540M |
| 3 |
Adobe
ADBE
|
+$417M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$375M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 26.23% |
| 3 | Industrials | 12.33% |
| 4 | Consumer Discretionary | 11.49% |
| 5 | Financials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$1.12T
| $6.21B | 4.61% |
36,757,185
-1,218,139
| -3% | -$182M |
2013 Q2
30 quarters
|
|
|
2
Microsoft
MSFT
$4.01T
| $4.49B | 3.34% |
20,182,729
-1,696,560
| -8% | -$365M |
2013 Q2
30 quarters
|
|
|
3
Adobe
ADBE
$97.9B
| $4.31B | 3.2% |
8,615,785
-863,795
| -9% | -$417M |
2013 Q2
30 quarters
|
|
4
Amgen
AMGN
$235B
| $3.9B | 2.9% |
16,978,827
-428,255
| -2% | -$98.7M |
2013 Q2
30 quarters
|
|
5
Biogen
BIIB
$34.8B
| $3.87B | 2.88% |
15,822,066
+125,362
| +0.8% | +$32.3M |
2013 Q2
30 quarters
|
|
6
Texas Instruments
TXN
$255B
| $3.82B | 2.84% |
23,262,463
-1,791,760
| -7% | -$279M |
2013 Q2
30 quarters
|
|
7
Micron Technology
MU
$1.05T
| $3.65B | 2.71% |
48,550,259
-1,857,250
| -4% | -$112M |
2013 Q2
30 quarters
|
|
8
FedEx
FDX
$69.9B
| $3.56B | 2.65% |
13,717,339
-269,300
| -2% | -$74.6M |
2013 Q2
30 quarters
|
|
9
Tesla
TSLA
$1.43T
| $3.47B | 2.58% |
14,733,105
-1,109,220
| -7% | -$189M |
2013 Q2
30 quarters
|
|
10
Southwest Airlines
LUV
$20B
| $3.04B | 2.26% |
65,213,818
-2,325,630
| -3% | -$101M |
2013 Q2
30 quarters
|
|
11
Sony
SONY
$144B
| $2.97B | 2.21% |
147,050,845
-10,831,550
| -7% | -$188M |
2013 Q2
30 quarters
|
|
12
Alibaba
BABA
$276B
| $2.91B | 2.16% |
12,509,686
-304,920
| -2% | -$84.7M |
2014 Q3
25 quarters
|
|
13
AstraZeneca
AZN
$259B
| $2.5B | 1.86% |
25,054,473
-694,558
| -3% | -$73.6M |
2015 Q3
21 quarters
|
|
14
Alphabet (Google) Class A
GOOGL
$4.27T
| $2.43B | 1.8% |
27,704,100
-2,946,120
| -10% | -$248M |
2015 Q3
21 quarters
|
|
15
KLA
KLAC
$228B
| $2.42B | 1.8% |
93,643,190
-2,621,700
| -3% | -$61.1M |
2013 Q2
30 quarters
|
|
16
Thermo Fisher Scientific
TMO
$258B
| $2.07B | 1.54% |
4,445,525
-152,716
| -3% | -$71.6M |
2013 Q4
28 quarters
|
|
17
Novartis
NVS
$286B
| $2.06B | 1.53% |
21,805,450
-765,490
| -3% | -$66.9M |
2013 Q2
30 quarters
|
|
18
Baidu
BIDU
$28.1B
| $2.06B | 1.53% |
9,512,376
+138,741
| +1% | +$20.6M |
2019 Q4
4 quarters
|
|
19
NetApp
NTAP
$42.2B
| $1.85B | 1.38% |
27,998,458
-1,123,400
| -4% | -$59.4M |
2013 Q2
30 quarters
|
|
|
20
Alphabet (Google) Class C
GOOG
$4.22T
| $1.85B | 1.37% |
21,117,040
-4,448,960
| -17% | -$375M |
2013 Q2
30 quarters
|
|
21
JPMorgan Chase
JPM
$891B
| $1.84B | 1.37% |
14,463,795
-2,069,585
| -13% | -$231M |
2015 Q1
23 quarters
|
|
|
22
Qualcomm
QCOM
$191B
| $1.76B | 1.31% |
11,584,518
-6,061,765
| -34% | -$844M |
2013 Q2
30 quarters
|
|
|
23
Intel
INTC
$504B
| $1.62B | 1.21% |
32,574,166
+7,151,405
| +28% | +$349M |
2013 Q2
30 quarters
|
|
24
BioMarin Pharmaceuticals
BMRN
$10.8B
| $1.59B | 1.18% |
18,147,961
-43,580
| -0.2% | -$3.46M |
2013 Q2
30 quarters
|
|
25
Charles Schwab
SCHW
$163B
| $1.51B | 1.12% |
28,459,569
-135,290
| -0.5% | -$6.12M |
2013 Q2
30 quarters
|
|
Similar funds
Primecap Management's Q4 2020 Portfolio in Review
As of Q4 2020, Primecap Management held 330 positions worth $135B, up 11% from $121B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management withdrew a net $5.25B in Q4 2020, closing 11 positions and reducing 193 holdings. Its most notable exit was E*Trade Financial Corporation, an estimated $540M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Morgan Stanley worth $827M.
- Primecap Management's largest Q4 2020 buy was Morgan Stanley: 12,072,976 shares worth $827M.
- Primecap Management added most to Intel in Q4 2020, an estimated $349M increase.
- Primecap Management's biggest Q4 2020 reduction was Qualcomm, cutting an estimated $844M.
- Primecap Management fully exited E*Trade Financial Corporation in Q4 2020, selling an estimated $540M.
- Primecap Management's ten largest holdings make up 30% of its $135B portfolio in Q4 2020.
- Primecap Management opened 19 new positions and closed 11 in Q4 2020.
- Primecap Management's portfolio value rose 11% quarter-over-quarter to $135B.
Based on Primecap Management's 13F filing for Q4 2020, filed 8 Feb 2021.